Schedule 13G ownership disclosure

Praxis Precision Medicines Inc

Common Stock, par value $0.0001 per share · CUSIP: 74006W207

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 1,503,376.00 · Class: 5.9%

  • Point72 Capital Advisors, Inc.

    Shares: 1,503,376.00 · Class: 5.9%

  • Point72 Biotech Private Investments, LLC

    Shares: 65,933.00 · Class: 0.3%

  • Differentiated Ventures Investments, LLC

    Shares: 65,933.00 · Class: 0.3%

  • 72 Investment Holdings, LLC

    Shares: 65,933.00 · Class: 0.3%

  • Steven A. Cohen

    Shares: 1,569,309.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001140
Form type
SCHEDULE 13G/A
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub